Variable | OR | 95% Confidence interval | p-Value |
---|---|---|---|
Intercept | 0.21 | 0.03–1.08 | 0.08 |
Type of technology: medicines | 0.70 | 0.29–1.76 | 0.43 |
Demander | |||
Government | 0.39 | 0.09–2.14 | 0.24 |
Private sector | 0.69 | 0.17–3.61 | 0.63 |
Social | 0.44 | 0.04–3.64 | 0.45 |
Indication | |||
Neoplasms | 0.81 | 0.28–2.08 | 0.67 |
Infectious and parasitic diseases | 0.45 | 0.07–1.71 | 0.31 |
Endocrine, nutritional and metabolic diseases | 0.94 | 0.36–2.29 | 0.90 |
Diseases of the musculoskeletal system and connective tissue | 0.84 | 0.26–2.28 | 0.74 |
Number of contributions in public consultation | |||
Large volume of contributions: total of participants | 1.22 | 0.33–3.84 | 0.75 |
Large volume of contributions: patients | 3.87 | 1.33–13.35 | 0.02 |
Large volume of contributions: public health institutions and professionals | 1.07 | 0.44–2.70 | 0.87 |
Large volume of contributions: other participants | 0.97 | 0.40–2.30 | 0.94 |
Number of contributions: private sector | 1.03 | 0.97–1.07 | 0.25 |
Number of contributions: public health managers | 0.91 | 0.77–1.03 | 0.19 |